Richard Park, MD
Cardiovascular Disease · Elgin, ILNPI 1568579027
Payments from drug & device makers
Across 271 payments — averaging $92.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$12K
- Edwards Lifesciences$6K
- Abbott$2K
- Boston Scientific$2K
- Medtronic$849
- Abiomed$430
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$8,55034%
- Travel & lodging$6,46426%
- Food & beverage$9,99940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 46 | $12,389 |
| Edwards Lifesciences | 57 | $6,020 |
| Abbott | 57 | $1,887 |
| Boston Scientific | 35 | $1,792 |
| Medtronic(2 entities) | 14 | $849 |
| Abiomed | 8 | $430 |
| Johnson & Johnson | 5 | $252 |
| Cook Medical LLC | 5 | $197 |
| Biotronik Inc. | 7 | $169 |
| E.r. Squibb & Sons, L.L.C. | 8 | $138 |
| Bolton Medical Inc | 2 | $137 |
| Amgen | 6 | $132 |
| Pfizer | 5 | $101 |
| Penumbra, Inc. | 1 | $90 |
| Boehringer Ingelheim | 3 | $76 |
| Shockwave Medical, Inc | 1 | $64 |
| Bard Peripheral Vascular, Inc. | 1 | $54 |
| Terumo Medical Corporation | 2 | $48 |
| Novartis | 1 | $33 |
| Bridgebio Pharma, Inc. | 1 | $29 |
| Veryan Medical Incorporated | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $24 |
| Teleflex LLC | 1 | $23 |
| Livanova USA, Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXCLUDER AAA Endoprosthesis$8,550
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,352
- GORE TAG Thoracic Endoprosthesis$1,522
- STINGRAY$865
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$850
- GORE TAG Thoracic Branch Endoprosthesis$718
- GORE TAG Conformable Thoracic Endoprosthesis$628
- SAPIEN 3 Ultra RESILIA$500
- CoreValve Evolut$362
- Impella$309
- MitraClip$279
- XARELTO$230
- GORE EXCLUDER Iliac Branch Endoprosthesis$226
- SUPERA$148
- PERCLOSE PROGLIDE$133
- XACT$130
- ABSOLUTE PRO$124
- Watchman$106
- 3F$106
- NAVITOR$102
How this compares
$25,014 in reported general payments places this provider in the 85th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 213 | $244,587 |
| XareltoRivaroxaban | 84 | $94,062 |
| MultaqDronedarone Hcl | 41 | $59,810 |
| EntrestoSacubitril/Valsartan | 31 | $38,879 |
| Repatha SureclickEvolocumab | 13 | $10,565 |
| ClopidogrelClopidogrel Bisulfate | 291 | $3,441 |
| Metoprolol Succinate | 221 | $3,340 |
| Diltiazem 12hr ErDiltiazem Hcl | 12 | $1,644 |
| Carvedilol | 117 | $1,463 |
| Atorvastatin Calcium | 201 | $1,419 |
| Amlodipine Besylate | 157 | $1,305 |
| Amiodarone Hcl | 24 | $1,157 |
| Losartan Potassium | 96 | $1,068 |
| Metoprolol Tartrate | 105 | $962 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 43 | $944 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $101 | $244,587213 claims |
| Johnson & JohnsonXarelto | $252 | $94,06284 claims |
| NovartisEntresto | $33 | $38,87931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 932 cardiovascular disease providers in Illinois.
Other cardiovascular disease in Elgin
- Azmey MatariehElgin$762K
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.